Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael Graglia from SynGAP Research Fund, discussing the importance of diagnosing #raredisease early and the critical step of sharing study data.
How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between...
"Humans have the right to study themselves." - Jamie Heywood, CEO at Alden Scientific Welcome back to Part 2 of our special Few &...
"It's amazing how many companies there are and how many opportunities for a kind of a match between a human that needs some help...